Navigation Links
CVS Caremark Ready to Support Patients and Payors Through Coming Era of Health Care Expansion
Date:10/8/2010

mary care.

"We are excited by the enormity of the opportunity to deliver on the health care community's shared goal of improving Americans' quality of life through care that is more innovative, easier to access and more cost-effective," Ryan said. "The role of the pharmacist is evolving, and our innovative solutions like Pharmacy Advisor and Maintenance Choice are great examples of how our pharmacists will have an expanded role in managing chronic disease for our customers and our plan members."

Ryan and other executives plan to highlight several key components of the company's integrated approach to meeting the country's long-term health care needs:

  • Pharmacy Advisor: This new program harnesses the power of one-on-one consultations with pharmacists to help PBM plan members improve their health by increasing adherence and reducing gaps in care.  Following a successful pilot phase, the program already has 7.8 million CVS Caremark PBM plan members set to start in January 2011.
  • Maintenance Choice: This program allows plan sponsors and plan members the opportunity to receive the savings typically associated with mail-order pharmacy whether members receive their 90-day maintenance medications by mail or at a local CVS/pharmacy location. By adding more convenience to the savings of mail-order pharmacy, Maintenance Choice is improving prescription adherence, thereby reducing unnecessary medical complications.
  • Health IT: The company has invested in advanced technologies that today help consumers find the most cost-effective medication for their conditions, avoid negative drug interactions and improve their prescription adherence. These recent investments also have increased efficiency.
  • Pharmacogenomics: CVS Caremark's innovative approach to genetic testing to determine appropriate therapies will match patients with the right drugs.
  • MinuteClinic: With patient visits to MinuteClinic continuing to grow, the company's ne
    '/>"/>

  • SOURCE CVS Caremark
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. CVS Caremark Appoints Jonathan C. Roberts as PBM Chief Operating Officer
    2. CVS Caremark Recognizes Its 26,000 Pharmacists During Octobers American Pharmacists Month
    3. NCPA Commends Senate Aging Committee for Launching CVS Caremark Investigation to Examine Alleged Harm to Seniors, Medicare
    4. CVS Caremark Announces 2010 Analyst Day
    5. CVS Caremark Corporation Announces Quarterly Dividend
    6. CVS Caremark Maintenance Choice Program Improves Medication Adherence for US Airways Employees and Dependents
    7. CVS Caremark Presents Ongoing Behavioral Change Research Partnership Research to the Pittsburgh Business Group on Health
    8. CVS Caremark to Offer $5 Million in Free Flu Shots to Uninsured Patients of Community Clinics and Health Centers Beginning September 20
    9. CVS Caremark Behavioral Change Research Partnership Presents Ongoing Research at Center for Disease Control Symposium
    10. NCPA Statement on CVS Caremark-Aetna Agreement
    11. CVS Caremark Corporation to Hold Conference Call to Discuss:
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/31/2015)... PGI has announced an expansion of its ... at its San Luis Potosi, ... expansion is centered on solving the challenge of complicated ... personal care product manufacturers. The planned ... and packaging, will allow customers to take advantage of ...
    (Date:3/31/2015)... , March 31, 2015  InMed Pharmaceuticals Inc. ... biopharmaceutical company that specializes in developing safer, more ... Paul C. Anderson , Ph.D., to its ... industry veteran who brings significant drug discovery and ... is a synthetic organic chemist by training with ...
    (Date:3/31/2015)... March 31, 2015 ANI Pharmaceuticals, Inc. ("ANI") ... Propafenone Hydrochloride 150mg, 225mg and 300mg oral tablets, indicated ... overall US market for Propafenone Hydrochloride 150mg, 225mg and ... Health. Arthur S. Przybyl , President ... announce the launch of our fourth product from the ...
    Breaking Medicine Technology:PGI Expands Manufacturing Capabilities At Mexico Plant 2InMed Pharmaceuticals Strengthens Scientific Advisory Board 2InMed Pharmaceuticals Strengthens Scientific Advisory Board 3InMed Pharmaceuticals Strengthens Scientific Advisory Board 4ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3
    ... ofatumumab has activity in heavily pre-treated patients who have ... , PHILADELPHIA, Dec. 8 ... positive results from a pivotal trial pre-planned interim analysis ... lymphocytic leukemia (CLL). The results demonstrate the potential of ...
    ... Dec. 8 Alexion Pharmaceuticals,Inc. (Nasdaq: ... from AEGIS, an open-label,registration study examining Soliris(R) ... hemoglobinuria (PNH). The pre-specified,primary efficacy endpoint of ... 86,percent reduction (P<0.001). Key secondary endpoints including ...
    Cached Medicine Technology:Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 2Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 3Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 4Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 5Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 6Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 7Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 8Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 9Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 2Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 3Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 4Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 5Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 6Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 7Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 8
    (Date:3/31/2015)... The Oliver Law Group P.C. has ... to client requests after Zofran lawsuits were filed in ... (GSK) failed to warn physicians and their patients about ... and “illegally and fraudently” promoted Zofran as a treatment ... for that use from the U.S. Food and Drug ...
    (Date:3/31/2015)... The status of more than 1,000 ... Case Management Conference scheduled to be held in the ... April 21st. According to court documents, the jurisdiction is ... Mirena lawsuits filed on behalf of women who allegedly ... related to the birth control device. (In re: Mirena ...
    (Date:3/31/2015)... Rising rates of anterior cruciate ligament ... surgeons to better analyze and investigate ways to improve ... A recent study published online in Sports ... 1,016 young, very active patients to compare ACL failure ... is the first review to examine young, active patients ...
    (Date:3/31/2015)... These two automakers will address an ... They will highlight a shift that has become apparent ... a business proposition for the insurance carriers alone. With ... opportunities that lie in store for them. ... are now alive to their own involvement in the ...
    (Date:3/31/2015)... 31, 2015 April is Parkinson’s disease Awareness ... to announce 30 Days, 30 Ways to Make a Difference. ... campaign that will offer a new action each day throughout ... those who battle this disease. , Every nine ... April alone nearly 5,000 individuals in this country will learn ...
    Breaking Medicine News(10 mins):Health News:Zofran Lawsuit Information Page Launched In Response To Clients Request For Information On Potential For Zofran Birth Defects, The Olive Law Group 2Health News:Zofran Lawsuit Information Page Launched In Response To Clients Request For Information On Potential For Zofran Birth Defects, The Olive Law Group 3Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 2Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 3Health News:ACL Failure Risks Increased in Young Patients Using Allografts 2Health News:TU-Automotive: Fiat and Renault-Nissan at the Centre of a Motor Insurance Evolution 2Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 2Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 3
    ... ARBOR, Mich. -- As the Diagnostic and Statistical Manual of ... controversy about psychiatric diagnosis is reaching a fever pitch. ... and depression, among others, are eliciting great concerns. However, there ... "Almost no one likes the DSM, but no one ...
    ... (HealthDay News) -- Babies can understand many words sooner than ... Researchers from the University of Pennsylvania say 6- to 9-month ... foods and body parts through their daily exposure to language. ... comprehension is possible until a child is closer to 1 ...
    ... Fla. February 15, 2012 Sanford-Burnham Medical ... returned from Japan where they reviewed the progress ... their research partnership with Takeda Pharmaceutical Company Limited ... and evaluation of new therapeutic approaches to obesity. ...
    ... Researchers from the University of Exeter, Peninsula College of ... the South Western Ambulance Service NHS Foundation Trust (SWASFT) ... Trust (RD&E) to reduce the time it takes from ... vital clot-busting drug treatment. The researchers are from ...
    ... Laser light in combination with certain drugs known as ... used mostly to cure skin cancer. The reason that internal ... technology does not exist to check that the precise amount ... atomic physics at Lund University in Sweden looks like being ...
    ... problems developing motor skills, such as running, throwing a ball ... known whether those difficulties run in families or are linked ... in St. Louis points to autism as the culprit. ... "From our results, it looks like motor impairments ...
    Cached Medicine News:Health News:Psychiatric diagnoses: Why no one is satisfied 2Health News:Babies May Be Smarter Than You Think 2Health News:Sanford-Burnham and Florida Hospital review obesity research progress with Takeda Pharmaceutical 2Health News:Sanford-Burnham and Florida Hospital review obesity research progress with Takeda Pharmaceutical 3Health News:Operational research seeks benefit for stroke victims 2Health News:Operational research seeks benefit for stroke victims 3Health News:New method makes it easier to treat prostate and pancreatic cancer 2Health News:Autism affects motor skills, study indicates 2Health News:Autism affects motor skills, study indicates 3
    Bimod, acetabular cup "Xl" UHMWHDPE....
    Metal on metal hip acetabular cups available for both cemented and cementless applications, the Biomet Merck metal on metal articulation hip system (M2aTM) combines proven materials with the latest i...
    S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
    Duraloc acetabular cup system....
    Medicine Products: